METHOD FOR TREATMENT OF IMPAIRED GLUCOSE TOLERANCE Russian patent published in 2006 - IPC A61K31/427 A61K31/426 A61P5/48 

FIELD: medicine, endocrinology.

SUBSTANCE: invention relates to methods used in treatment of the impaired glucose tolerance in aim for prophylaxis or postponement of invasion of insulin-independent diabetes mellitus. Variants of method involves administration in patient compounds of the formula (I) or (II) or their pharmaceutically acceptable salts describes in the invention claim, in particular, such compounds as (+)-5-[[4-[(3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]-2,4-thiazolidinedione, pioglitazone, ciglitazone. Invention provides prevention of insulin-independent diabetes mellitus development by decrease of insulin insufficiency and normalization of tolerance to glucose in clinically health patients no having the enhanced basal levels of blood glucose.

EFFECT: improved treatment method.

9 cl, 4 tbl, 1 ex